Standout Papers

Endothelial cells in physiology and in the pathophysiology of vascular disorders. 1998 2026 2007 2016 1.8k
  1. Endothelial cells in physiology and in the pathophysiology of vascular disorders. (1998)
    Douglas B. Cines, Eleanor S. Pollak et al. Blood
  2. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial (2015)
    Joshua N. Goldstein, Majed A. Refaai et al. The Lancet
  3. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation (2025)
    Christian T. Ruff, Siddharth M. Patel et al. New England Journal of Medicine

Immediate Impact

12 by Nobel laureates 19 from Science/Nature 53 standout
Sub-graph 1 of 22

Citing Papers

Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Immune checkpoint inhibitors in melanoma
2021 Standout
1 intermediate paper

Works of Bruce A. Hug being referenced

Phase 1 study of the BRAF inhibitor dabrafenib (D) with or without the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation–positive unresectable or metastatic melanoma (MM).
2014
ETO interacting proteins
2004

Author Peers

Author Last Decade Papers Cites
Bruce A. Hug 1537 597 329 584 46 3.5k
Hetty C. de Boer 1681 613 421 653 73 3.6k
Nicole C. Kaneider 1068 900 256 720 62 3.2k
Mitsuhiko Okigaki 1724 318 269 828 65 4.1k
Colin N. Chesterman 1693 976 182 595 66 4.0k
Koichiro Mihara 1209 461 240 324 69 2.6k
Giuseppe Montrucchio 861 497 130 595 69 2.7k
Ronald L. Heimark 2367 438 354 300 58 4.1k
Elisabeth M. Battinelli 1063 901 189 351 50 2.7k
Anna M. Randi 2125 924 326 821 95 4.7k
David A. Goukassian 1330 281 235 474 76 2.9k

All Works

Loading papers...

Rankless by CCL
2026